Annual Drug Patent Expirations for OCALIVA
Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for OCALIVA.
This drug has one hundred and six patent family members in thirty-four countries.
The generic ingredient in OCALIVA is obeticholic acid. One supplier is listed for this compound. Additional details are available on the obeticholic acid profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
